James Conner
Overview
Explore the profile of James Conner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
674
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Luu S, Fu N, Savage P, Pacholczyk K, Zaslavsky T, Conner J, et al.
J Gastrointest Oncol
. 2024 Sep;
15(4):1870-1879.
PMID: 39279976
On a global scale, gastric adenocarcinoma (GCa) accounts for a large burden of death from cancer. Despite advances in systemic therapy and surgical technique, the fatality rate for GCa remains...
2.
Upadhyay A, Gradwell M, Vajtay T, Conner J, Sanyal A, Azadegan C, et al.
bioRxiv
. 2024 May;
PMID: 38712022
Tactile perception relies on reliable transmission and modulation of low-threshold information as it travels from the periphery to the brain. During pathological conditions, tactile stimuli can aberrantly engage nociceptive pathways...
3.
Sinicrope F, Nelson G, Saberzadeh-Ardestani B, Segovia D, Graham R, Wu C, et al.
Cancer Res Commun
. 2024 May;
4(5):1344-1350.
PMID: 38709069
Significance: A deep learning algorithm can quantify tumor morphologic features that may reflect underlying mechanisms driving prognosis within MMR groups. TSR was the most robust morphologic feature associated with TTR...
4.
Wu C, Pai R, Kosiorek H, Banerjee I, Pfeiffer A, Hagen C, et al.
Clin Cancer Res
. 2024 Feb;
30(9):1811-1821.
PMID: 38421684
Purpose: There is a need to improve current risk stratification of stage II colorectal cancer to better inform risk of recurrence and guide adjuvant chemotherapy. We sought to examine whether...
5.
Pai R, Banerjee I, Shivji S, Jain S, Hartman D, Buchanan D, et al.
Gastroenterology
. 2022 Aug;
163(6):1531-1546.e8.
PMID: 35985511
Background & Aims: To examine whether quantitative pathologic analysis of digitized hematoxylin and eosin slides of colorectal carcinoma (CRC) correlates with clinicopathologic features, molecular alterations, and prognosis. Methods: A quantitative...
6.
Ng D, Ali A, Lee K, Eymael D, Abe K, Luu S, et al.
Sci Rep
. 2022 Jul;
12(1):11499.
PMID: 35798764
Gastric adenocarcinoma, commonly known as stomach cancer, has a predilection for metastasis to the peritoneum, which portends limited survival. The peritoneal metastatic cascade remains poorly understood, and existing models fail...
7.
Shivji S, Cyr D, Pun C, Duan K, Sari A, Tomin R, et al.
Am J Surg Pathol
. 2022 May;
46(10):1340-1351.
PMID: 35613045
Tumor budding (TB) and poorly differentiated clusters (PDCs) are powerful prognostic factors in colorectal cancer (CRC). Despite their morphologic and biological overlap, TB and PDC are assessed separately and are...
8.
Shibahara Y, Espin-Garcia O, Conner J, Weiss J, Derouet M, Allen J, et al.
Cureus
. 2022 Feb;
14(1):e21021.
PMID: 35154991
Purpose Intestinal stem cell markers play a significant role in esophageal adenocarcinoma carcinogenesis via Barrett's esophagus; however, its utility as a prognostic biomarker has not been established. Methods We analyzed...
9.
Hernandez-Rocha C, Nayeri S, Turpin W, Steel M, Borowski K, Stempak J, et al.
J Crohns Colitis
. 2022 Jan;
16(7):1020-1029.
PMID: 34999763
Background And Aims: A composite endpoint of histological and endoscopic remission is proposed to be the most complete measure of mucosal healing in ulcerative colitis [UC]. We aim to establish...
10.
Sari A, Cyr D, Brar A, Messenger D, Driman D, Shivji S, et al.
Am J Surg Pathol
. 2021 Aug;
46(2):200-212.
PMID: 34411028
Venous invasion (VI) is a powerful yet underreported prognostic factor in colorectal cancer (CRC). Its detection can be improved with an elastin stain. We evaluated the impact of routine elastin...